Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2023
Source ID
10.1016/j.isci.2023.107487

Entities

People

  • Amrie C. Grammer
  • Andrea R. Daamen
  • Chih-Hao Chang
  • Colleen L. Mayberry
  • Derry C. Roopenian
  • Elaine Bechtel
  • Grace A. Stafford
  • Jian Wei
  • John D. Sears
  • John J. Wilson
  • Lesley Bechtold
  • Peter E. Lipsky

Organizations

  • Jackson Laboratory
  • United States Department of Defense